Evidence map›Paper›PMID 21731694›Full record

ArticlePloS one2011

Control of centrin stability by Aurora A.

Kara B Lukasiewicz, Tammy M Greenwood, Vivian C Negron, Amy K Bruzek, Jeffrey L Salisbury, Wilma L Lingle

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Three-dimensional cellular dynamics and mandibular morphogenesis.Frontiers in cell and developmental biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Suppressor of cytokine signaling 1 blocks mitosis in human melanoma cells.Cellular and molecular life sciences : CMLS · 2013
    Article
  17. Aurora A kinase (AURKA) in normal and pathological cell division.Cellular and molecular life sciences : CMLS · 2013
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kara B LukasiewiczDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, United States of America.
Tammy M Greenwood
Vivian C Negron
Amy K Bruzek
Jeffrey L Salisbury
Wilma L Lingle
Mayo Clinic · US

Funding

The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI PETER C LUCAS · 2005 to 2026
$49.9M
CENTROSOME HYPERTROPHY IN HUMAN BREAST TUMORSR01CA072836 · NCI · MAYO CLINIC ROCHESTER · PI SALISBURY, JEFFREY L · 1998 to 2006
$1.9M
NCI NIH HHS CA116201NCI NIH HHS P50 CA116201NCI NIH HHS R01 CA072836
6 · The paper itself

Abstract

Aurora A is an oncogenic serine/threonine kinase which can cause cell transformation and centrosome amplification when over-expressed. Human breast tumors show excess Aurora A and phospho-centrin in amplified centrosomes. Here, we show that Aurora A mediates the phosphorylation of and localizes with centrin at the centrosome, with both proteins reaching maximum abundance from prophase through metaphase, followed by their precipitous loss in late stages of mitosis. Over-expression of Aurora A results in excess phospho-centrin and centrosome amplification. In contrast, centrosome amplification is not seen in cells over-expressing Aurora A in the presence of a recombinant centrin mutant lacking the serine phosphorylation site at residue 170. Expression of a kinase dead Aurora A results in a decrease in mitotic index and abrogation of centrin phosphorylation. Finally, a recombinant centrin mutation that mimics centrin phosphorylation increases centrin's stability against APC/C-mediated proteasomal degradation. Taken together, these results suggest that the stability of centrin is regulated in part by Aurora A, and that excess phosphorylated centrin may promote centrosome amplification in cancer.

Indexed as

Anaphase-Promoting Complex-CyclosomeAurora KinasesCalcium-Binding ProteinsCell Cycle ProteinsCell ProliferationCentrosomeHeLa CellsHumansMitosisMutationPhosphorylationProtein BindingProtein Serine-Threonine KinasesProtein StabilityProtein TransportSerineAnaphase-Promoting Complex-CyclosomeAurora KinasesCalcium-Binding ProteinsCell Cycle ProteinsCETN2 protein, humanProtein Serine-Threonine KinasesSerineUbiquitin-Protein Ligase Complexes

Identifiers

PMID21731694
PMCPMC3121746
OpenAlexW2094438335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.